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Abstract
Background. The recent data suggest that sleep disorders are associated with cardiovascular diseases. We assessed 
the relation between self-reported sleep duration and cardiovascular and metabolic disorders in the large-scale epi-
demiological study. 
Material and methods. The ESSE-RF is a population-based cross-sectional study involving 22,258 participants aged 
25–64 years from 13 regions of the Russian Federation. In 2012–2014, all subjects underwent a structured inter-
view including questions about average daily sleep duration, lifestyle, complaints and diseases. The current analyses 
considered the associations with the following disorders: obesity, hypertension, coronary artery disease, myocardial 
infarction, stroke (cerebral thrombosis or hemorrhage) and diabetes mellitus. 
Results. Altogether 20,359 respondents were included in the final analysis. The mean self-reported sleep duration 
was 7.0 h per night: 23.3% participants reported sleeping less than 6 h while 4.5% subjects slept more than 9 h. We 
found both short and long sleep duration to be associated with self-reported cardiovascular diseases. The associa-
tion was independent of age, sex, body mass index, blood pressure, lipids and glucose levels. The multivariable odds 
were higher for obesity in short-sleepers compared to those sleeping 7–8 h. In the meanwhile, the association was  
U-shaped for coronary artery disease. A J-shaped relation was found for myocardial infarction. No relation was found 
for hypertension, diabetes mellitus or stroke. 
Conclusions. Differences in sleep duration may have health consequences given associations between short and long 
sleep duration and cardiometabolic outcomes.
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Introduction
Increasing evidence indicates that sufficient sleep 
duration and sleep quality are important for the pri-
mary and secondary cardiovascular prevention [1, 2]. 
The leading sleep medical associations recommend 
7–9 hours of daily sleep for adults [3–5]. The associa-
tion between the cardiovascular event risk and sleep 
duration is characterized by the U-shape curve which 
implies different mechanisms affecting prognosis 
in the long- and short-sleepers [6]. Moreover, the 
majority of cross-sectional and observational stud-
ies show an increased rate of obesity, cardiovascular 
diseases, stroke and mortality in subjects with poor 
sleep quality, as well as in short- and long-sleepers 
[7]. A number of experimental studies showed that 
short sleep is potentially associated with the adverse 
endocrine, immune, and metabolic effects. However, 
the underlying mechanisms remain unclear. Nev-
ertheless, the following mechanisms are discussed: 
sympathetic activation, disruption of energy balance, 
proinflammatory state, impaired insulin sensitivity, 
enhancement of lipid metabolism abnormalities, etc. 
[8–10]. Experimental studies demonstrated blood 
pressure elevation after one night of partial sleep de-
privation [11] and its decline after sleep prolongation 
[12]. All these factors are known to be involved in 
the cardiovascular continuum promoting atheroscle-
rosis progression and increasing risk of cardiovascular 
events [4]. Some authors indicate that different sleep 
duration and sleep disturbances might be associ-
ated with different outcomes. Thus, CARDIA study 
showed that long sleep duration is mostly associated 
with increased risk of dyslipidemia [13]. Cross-sec-
tional and prospective studies demonstrated that the 
prevalence of stroke and myocardial infarction (MI) 
is higher in both short and long sleepers, but the 
sleep debt mostly increases risk of MI [7, 14]. 
Complaints related to short sleep and poor sleep 
quality are more often reported by elderly people. 
Some studies showed that these changes are more 
frequent and start earlier in women than in men 
[15]. Moreover, based on the Whitehall II Study, 
only in women short duration of sleep is associated 
with higher risks of hypertension. The gender-related 
differences are mostly explained by the effects of sex 
hormones, and in particular major hormonal shifts 
more pronounced in women than in men. At the 
same time, psychosocial and behavioral factors can 
also have an impact on sleep characteristics in men 
and women [16].
The multicenter study “Epidemiology of cardio-
vascular disease in different regions of the Russian 
Federation — ESSE-RF” is the first epidemiological 
study to evaluate the sleep duration among Rus-
sians [17]. The main objective of this epidemiological 
study was to study the prevalence of risk factors and 
cardiovascular diseases in 13 regions of the Russian 
Federation (RF) with different climate, geographic, 
economic and demographic characteristics, to elabo-
rate the risk model for Russian population, and to 
investigate the traditional and new cardiovascular 
risk factors. We hypothesize that short and long sleep 
can be one of the new possible risk factors for cardio-
vascular diseases (CVD).
The aim of this cross-sectional analysis was to in-
vestigate the relationship between self-reported sleep 
duration and various cardiovascular and metabolic 
disorders.
Material and methods
A representative population-based sample of male 
and female individuals aged 25 to 64 years old was 
enrolled from 13 Russian regions and cities (North 
Ossetia — Alania Republic (North Caucasus), Vol-
gograd (South), Vologda (North-West), Voronezh 
(Centre), Ivanovo (Centre), Kemerovo (West Sibe-
ria), Krasnoyarsk (East Siberia), Orenburg (Volga 
region), Vladivostok (Far East), St Petersburg (North 
West), Tomsk (West Siberia), Ekaterinburg (West 
Siberia), Tyumen (Ural)). The survey was accom-
plished within the period from November 1, 2012 
to November 25, 2014. The study was approved by 
the Institutional Review Boards of 3 main centers: 
Almazov National Medical Research Centre (St Pe-
tersburg), National Research Center for Preventive 
Medicine (Moscow), Russian Cardiology Research 
and Production Complex (Moscow) and the associ-
ate centers. Detailed study design and enrollment 
process were described previously elsewhere [17]. 
All participants gave written informed consent. The 
response rate was on average 80%. 
Overall, 22,258 participants underwent the 
ESSE-RF survey (8541 men, 38.4%). Out of all 
included subjects, 1899 (8.5%) respondents were 
excluded due to the missing data: lab tests (n = 887), 
sleep module (n = 542); inconsistent data (n = 289); 
112, 16 and 53 did not report their height, weight 
and waist/hip ratio, respectively. Therefore, in to-
tal 20,359 respondents were included in the final 
analysis [7,746 men, 38%; mean age — 48 (25; 64) 
years].
All subjects underwent a structured interview. 
The questionnaire was designed on a modular type 
and included questions regarding social and demo-
graphic characteristics, life style and habits (includ-
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ing cigarette smoking, alcohol consumption and 
physical activity), anamnesis, etc. in accordance with 
the adapted international methods. Alcohol abuse 
was considered when ≥ 168 g of ethanol per week 
was consumed by men and ≥ 84 g of ethanol per 
week by women. The level of physical activity was 
considered low when a subject reported less than 
150 minutes of moderate or less than 75 minutes of 
intense aerobic physical activity per week, which is 
the recommended minimum level for adults (walk-
ing at medium or high speed, or any other equiva-
lent activity) [18].
History was recorded in the module “diseases” by 
answering the question “Have your doctor ever told 
that you have/had the following diseases?” followed 
by the list of 17 pathologies. In the present paper, 
we analyzed hypertension, coronary artery disease 
(CAD), myocardial infarction (MI), stroke (cerebral 
thrombosis or hemorrhage), obesity, and diabetes 
mellitus (DM). Participants were asked to provide 
information about average sleep duration in hours 
(during one month before the survey): “What was 
your daily sleep duration? Please, include the naps”. 
Sleep duration of 6 hours or less was considered short 
[19], ≥ 9 hours was considered long [20]. Physical 
examination included anthropometric measurements 
(waist circumference, height, and weight). Body 
mass index (BMI) was calculated by Quetelet index 
— body weight [kg]/height2 [m2]. Obesity was diag-
nosed in case of BMI ≥ 30 kg/m2. Hypertension was 
considered when office systolic blood pressure (SBP) 
was ≥ 140 mm Hg and/or diastolic blood pressure 
(DBP) was ≥ 90 mm Hg or antihypertensive therapy 
was ongoing at the time of the survey. Blood samples 
were collected according to standardized protocols 
after ≥ 12-hour fasting on the day of the survey 
before the interview and anthropometric measure-
ments were taken. Blood samples were centrifuged 
at low speed 900 g for 20 minutes at +4∞C. Serum 
was immediately frozen and stored at temperature 
below –20∞C until they were transferred by special 
logistic services to the laboratory at the responsible 
participating center.
The following parameters were evaluated: total 
cholesterol, low density lipoprotein (LDL), high 
density lipoprotein (HDL), triglycerides, glucose, 
creatinine, uric acid (Abbot Architect c8000, USA). 
Glomerular filtration rate (GFR) was estimated by 
the formula CKD-EPI [21]. 
Statistical analysis
All statistical analyses were performed using IBM 
SPSS Statistics v.21 (USA). Each parameter was 
tested for normal distribution using the Kolmogo-
rov-Smirnov test. In case of normal distribution the 
parameters are presented as mean and standard devi-
ation. In case of non-normal distribution the param-
eters are presented as median and range (minimum; 
maximum). Comparative analysis of the quantita-
tive variables was performed using Student’s t-test. 
Fisher’s exact test and c2 were used for categorical 
variables. ANOVA was applied for multiple compari-
sons. Logistic regression analysis was used to deter-
mine predictors among categorical parameters. Sleep 
duration was included as dependent variable. Car-
diovascular diseases (hypertension, CAD etc.), meta-
bolic disorders and other traditional risk factors (age, 
BMI, office SBP and DBP, smoking, alcohol overuse, 
cholesterol levels, fasting glucose etc.) were included 
as independent variables in the univariate analysis. 
Those factors that had significant predictive value 
(p < 0.05) in the univariate analysis were included 
in a multivariate model (multinomial logistic regres-
sion). Closely correlated factors were not included 
in the same analysis (e.g. BMI in obesity analysis, 
glucose level in DM analysis etc.). We estimated odds 
ratios (ORs) and 95% confidence intervals (95% CI) 
for sleep parameters associated with each risk factor 
and disorder. Direct standardization of data reported 
from each region was performed according to the 
European standards. Differences were considered sig-
nificant at p-level < 0.05.
Results
Mean sleep duration was 7 (1; 16) hours. The 
life style characteristics were as following: 4440 
(21.8%) smokers, 674 (3.3%) subjects reported al-
cohol abuse, low physical activity (less than 5 times 
a week) — 14209 (69.8%) respondents. About one 
third of subjects (n = 7175, 35%) were overweight 
(25 ≤ BMI < 30 kg/m2), every fifth respondent 
(n = 4287, 21%) had obesity I degree, the rate of obe-
sity II and III degree was significantly lower (n = 1609, 
8% and n = 722, 4%, respectively). Every 20th patient 
(n = 939, 5%) had weight deficit (BMI <19.9 kg/m2). 
Normal fasting glucose level was found in 14961 
(74%) participants, while 2323 (11%) participants 
had impaired fasting glucose. Diabetes mellitus was 
newly diagnosed (based on fasting plasma glucose) 
in 1960 (10%) patients, while 968 (5%) participants 
reported previously diagnosed DM. All the subjects 
were divided into groups based on the sleep duration 
for the last month: ≤ 6 hours, 6 < sleep < 7 hours, 
7–8 hours, 8 < sleep ≤ 9 hours and > 9 hours of sleep 
(Tab. I). The majority of subjects reported 7–8 hours 
(33.3%) and from 6 to 7 hours (32.6%) of sleep 
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daily. Almost every 4th participant reported usual 
short sleep (23.3%), while only 4.5% were long-
sleepers. The similar distribution was found both in 
men and women. Subjects with longer sleep duration 
(> 9 hours) were younger compared to those sleeping 
≤ 6 hours. Prevalence of short-sleepers increased in 
elder subjects. 
Those sleeping > 8 hours had the lowest BMI, 
while short-sleepers had higher BMI values. SBP 
also increased in short sleepers. Heart rate, glucose 
and creatinine levels and GFR were also associated 
with sleep duration, while no significant relation was 
found between sleep duration and total cholesterol, 
LDL or triglycerides (Tab. II). At the same time 
Table I. Clinical and demographic characteristics of the study participants depending on sleep duration (n = 20359)
Variable All ≤ 6 hours 6 < sleep  < 7 hours 7–8 hours
8 < sleep  
≤ 9 hours > 9 hours p
Age (years) 48(25; 64)
50 
(25; 64)
48 
(25; 64)
48 
(25; 64)
47
 (25; 64)
46 
(25; 64) < 0.001
25–34
n = 4304 (%) 21.1 20.8 33.6 33.08 6.78 5.62
c2 = 84.822
p < 0.001
35–44
n = 4078 (%) 20 20.57 34.69 34.69 6.2 4.36
45–54
n = 5681 (%) 27.9 24.55 32.7 33.25 5.42 4.01
55–64
n = 6296 (%) 30.9 25.84 30.5 30.54 6.25 4.3
Gender, men/women 
n (%)
7746 (38%) 
12613 (62%)
1714 (22.1%) 
3045 (24.1%)
2590 (33.4%)
4057 (32.1%)
2695 (34.8%)
4092 (32.4%)
424 (5.4%)
823 (6.5%)
323 (4.1%)
596 (4.7%)
c2 = 30.6;
< 0.001
BMI [kg/m2] 27.4 (15; 68)
27.8 
(15; 68)
27.0 
(15; 59)
27.4 
(15; 54)
27.0 
(15; 53) 27.0 (16; 51) < 0.001
Waist circumference 
[cm]
Men, Women
92 (41; 160) 
85 (44; 160)
92 (55; 150)
87.5 (44; 160)
92 (52; 152)
85 (50; 160)
92 (41; 160)
86 (45; 143)
92 (48; 135)
84 (57; 35.5)
93 (60; 134)
85 (56; 146)
< 0.05
< 0.001
SBP [mm Hg] 131 (83; 233)
131 
(87; 240)
130 
(80; 240)
130 
(79; 240)
127 
(85; 222)
128 
(83;240) < 0.001
DBP [mm Hg] 81 (48; 137)
81 
(47;150)
81 
(40; 146)
81 
(40; 150)
80 
(48; 134)
81 
(44;130) < 0.001
HR [beat per min] 73 (42; 153)
73 
(43;150)
73 
(41; 165)
73 
(42; 135)
73 
(45; 132)
73  
(43;128) 0.042
Obesity
n = 6648 (%) 33 36.3 31.7 31.8 30.8 32.9
c2 = 34.5;
p < 0.001
DM (history)
n = 968 (%) 4.7 5.4 4.4 4.5 5.1 5.2
c2 = 7.2;
p = 0.13
Hypertension
n = 7670 (%) 38 40.8 36.7 37.1 34 37.6
c2 = 30;
p < 0.001
CAD
n = 2116 (%) 10.0 13.4 8.7 9.7 10.3 11.9
c2 = 70.6;
p < 0.001
MI
n = 443 (%) 2.2 2.6 1.7 2.2 2.6 2.8
c2 = 15.8;
p = 0.003
Stroke
n = 422 (%) 2.1 2.2 1.9 2.2 2.4 1.6
c2 = 4.2;
p = 0.4
Smoking
n = 4440 (%) 21.8 24.1 21.9 20.1 18.9 24.7
c2 = 37.4;
< 0.001
Alcohol abuse
n = 674 (%) 3.3 3.2 3.2 3.2 4.1 4.2 0.2
Low physical activity
n = 14209 (%) 69.8 57.3 71.6 70.0 77.4 59.4
c2 = 24.3;
< 0.001
BMI — body mass index; CAD — coronary artery disease; DBP — diastolic blood pressure; DM — diabetes mellitus; MI — myocardial infarction; SBP — systolic blood pressure
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HDL cholesterol was significantly lower in long-
sleepers. Gender-specific differences were shown for 
uric acid: the highest levels of uric acid were found 
in men sleeping 6–7 hours. 
Short- and long-sleepers less often had low physi-
cal activity (c2 = 24.3; p < 0.001) and smoked more 
often (c2 = 37.4; p < 0.001) than normal sleep-
ers. The rate of alcohol abuse was not significant in 
groups with different sleep duration.
We also found (Tab. I) a U-shaped relation be-
tween sleep duration and other cardiovascular risk 
factors and diseases: short- and long-sleepers had 
higher incidence of obesity, hypertension, CAD and 
MI. There were no significant differences for DM 
and stroke.
Logistic regression showed a higher probability of 
obesity, hypertension and CAD (Tab. III) in short-
sleepers. Six-to-seven-hour sleep was associated with 
Table II. Laboratory parameters of the study participants depending on sleep duration (n = 20,359)
Variable All ≤ 6 hours 6 < sleep < 7 hours 7–8 hours
8 < sleep ≤ 9 
hours > 9 hours p
Cholesterol [mmol/L] 5.4 (1.7; 15.7)
5.3 
(2.1; 14)
5.3 
(2.2; 11)
5.3 
(2.1; 12)
5.3
(2.4; 10)
5.3 
(2.2; 16) 0.64
LDL [mmol/L] 3.3 (0.5; 12.1)
3.3 
(0.5; 10)
3.3 
(0.6; 8.6)
3.3 
(0.7; 8.9)
3.3 
(1.0; 7.3)
3.2
(0.8; 12) 0.06
HDL [mmol/L] 1.4 (0.2; 3.8)
1.4 
(0.4; 3.8)
1.4 
(0.4; 3.9)
1.4 
(0.2; 3)
1.4 
(0.5; 2.8)
1.3 
(0.4; 3) 0.015
Triglyceride [mmol/L] 1.2 (0.1; 16.1)
1.2 
(0.1; 14)
1.2 
(0.1; 16)
1.2 
(0.2; 16)
1.2 
(0.3; 10)
1.2 
(0.3; 19) 0.15
Glucose [mmol/L] 5.1 (2.5; 25.5)
5.1 
(2.5; 24)
5.1 
(2.5; 25.5)
5.1 
(2.7; 22.5)
5.0 
(3; 24)
5.1 
(2.6; 21) 0.024
Creatinine [µmol/L] 69.3 (31; 918)
67.0 
(33; 734)
67.4 
(31; 700)
68.0 
(32; 653)
67.0 
(39; 461)
67.0 
(41; 918) 0.022
GFR  
[µmol/L/min × 1.73]
100 
(5.4; 173)
99.5 
(7; 152)
100.4 
(7; 173)
100.0 
(6; 166)
100.5 
(9; 138)
100.0 
(5; 138) 0.021
Uric Acid, [mmol/L] 
Men/Women
346 (81; 1000)
270 (80; 1130)
340 (110; 800) 
270 (80; 777)
350 (100; 1000)
270 (80; 1030)
341 (81; 850)
267 (80; 925)
344 (163; 650) 
260 (110; 1130)
330 (126; 810)
260 (89; 676)
< 0.05
> 0.05
HDL — high density lipoprotein; GFR — glomerular filtration rate; LDL — low density lipoprotein
Table III. Association between sleep duration and cardiovascular diseases (OR; 95% CI)
Sleep duration Obesity Diabetes Mellitus Hypertension 
Coronary Artery 
Disease 
Myocardial 
Infarction Stroke 
≤ 6 h
Model 1 1.2***(1.1; 1.3)
1.2*
(1.02; 1.4)
1.2*** 
(1.1; 1.3)
1.4*** 
(1.3; 1.6)
1.2 
(0.9; 1.5)
1.0
(0.8; 1.3)
Model 2 1.1**(1.04; 1.3)
1.0 
(0.9; 1.2)
1.1 
(1.0; 1.2)
1.3*** 
(1.2; 1.5)
1.1 
(0.9; 1.5)
0.9
(0.7; 1.2)
6 < sleep 
< 7 h
Model 1 1.0 (0.9; 1.1)
1.0 
(0.9; 1.2)
1.0 
(0.9; 1.1)
 0.8* 
(0.7; 0.9) 
0.7* 
(0.6; 0.9)
0.9 
(0.7; 1.1)
Model 2 1.0 (0.9; 1.1)
1.0 
(0.9; 1.2)
1.0 
(0.9; 1.1)
 0.9  
(0.8; 1.0) 
0.8
(0.6; 1.0)
0.9 
(0.7; 1.1)
7–8 h Reference variable
8 < sleep 
≤ 9 h
Model 1 1.0 (0.8; 1.1)
1.1 
(0.9; 1.5)
0.8* 
(0.7; 0.9)
1.1 
(0.9; 1.3)
1.2 
(0.8; 1.7)
1.1 
(0.7; 1.7)
Model 2 1.0 (0.9; 1.2)
1.2
(0.9; 1.6)
0.9 
(0.8; 1.1)
1.1
(0.9; 1.4)
1.3 
(0.9; 2.0)
1.2 
(0.8; 1.8)
> 9 h
Model 1 1.0(0.9; 1.2)
1.2 
(0.9; 1.6)
1.0 
(0.9; 1.2)
1.3* 
(1.02; 1.6)
1.3 
(0.8; 2.0)
0.8 
(0.4; 1.3)
Model 2 1.1 (0.9; 1,3)
1.3 
(0.9; 1.8)
1.1 
(1.0; 1.3)
1.5** 
(1.1; 1.8)
1.6* 
(1.02; 2.4)
0.8 
(0.5; 1.4)
Model 1 — unadjusted; Model 2 — adjusted for sex, age, body mass index, office blood pressure, smoking and low physical activity; *p < 0.05; **p < 0.01; ***p < 0.001
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lower probability of CAD and MI. Moreover, sleep 
duration from 8 to 9 hours was associated with the 
lowest risk of hypertension (OR = 0.8; CI: 0.7–0.9, 
p = 0.037). At the same time sleep over 9 hours was 
associated with the higher risk of CAD (OR = 1.3; 
CI: 1.02–1.6, p = 0.043). After adjustment for sex, 
age, BMI, office blood pressure, smoking and low 
physical activity the associations were weaker but 
remained significant (Tab. II). Compared with sub-
jects sleeping 7–8 h, the multivariable OR (95% CI) 
was higher for obesity in short-sleepers — 1.1 (1.03; 
1.2), meanwhile the association was U-shaped for 
CAD, and J-shaped for MI. No associations were 
found for hypertension, DM and stroke.
Discussion
Based on the data from the epidemiological study 
ESSE-RF the median sleep duration in Russian citi-
zens is 7 hours. Almost every 4th citizen (23.3%) is 
a short-sleeper. This conforms with the results of the 
National Health Interview Survey [22] — 29% (8% 
subjects sleeping ≤ 5 h/day and 21% those sleep-
ing 6 h/day), but the prevalence of short-sleepers 
among Russian population is significantly higher 
than the data reported in the Sleep Heart Health 
Study (9.2%) [23]. These differences are due to the 
various approaches for sleep assessment. The first 
study, similarly to ours, estimated average daily sleep 
duration, while the second one identified mean sleep 
duration on weekends and workdays. In both stud-
ies, the proportion of long-sleepers is greater than in 
our cohort — 4.5% vs. 7.6% and 9% in SHHS and 
NHIS, respectively.
Based on our analysis, short sleep duration is asso-
ciated with the increased risk of obesity, hypertension 
and CAD. The incidence of CAD and MI was higher 
for both short- and long-sleepers. No significant dif-
ferences between subjects with various sleep dura-
tion were found regarding alcohol abuse. However, 
short- and long-sleepers reported lower prevalence 
of low physical activity and smoked more frequently. 
Therefore, our data do not confirm any definite and 
unidirectional relationship between sleep duration 
and cardiovascular risk factors.
The data on sleep duration and sleep quality in 
Russian population is lacking. The ESSE-RF is the 
first study which estimated sleep duration in Rus-
sia. At the same time, sleep quality was assessed in 
few other studies. Participants of the HAPIEE study 
45–69 years old reported frequent spontaneous sleep 
interruptions in 20%; and unsatisfying sleep in 10% 
respondents [24]. Sleep quality was associated with 
angina, arthritis and depression in the analysis of 
the data from Russian population performed by the 
SAGE investigators [25]. 
Unlike other studies, our analysis did not show 
associations between short or long sleep duration 
with DM, hypertension or stroke. The Sleep Heart 
Health Study demonstrated higher risk for hyperten-
sion [23] for both short- (OR = 1.66, CI 1.35–2.04, 
p < 0.0001) and long-sleepers (OR = 1.30, 
CI: 1.04–1.62, p < 0.0001). In addition, both short-
sleepers (OR = 2.01, CI: 1.5–2.70, p < 0.005) and 
long-sleepers (OR = 2.22, CI: 1.69–2.91, p< 0.005) 
had higher risk of stroke [19]. The meta-analyses of 
24 prospective cohorts including 474 684 participants 
with short (≤ 5–6 h) (OR = 1.15, CI: 1.00–1.31, 
p = 0.047) and long sleep duration (> 8–9 h) 
(OR = 1.65, CI: 1.45–1.87, p < 0.0001) showed 
higher risk of fatal and non-fatal stroke compared to 
reference subjects sleeping 7–8 h per day [7].
Limitations of the study
One of the most significant limitations of our study 
is the absence of objective (instrumental) verification 
of sleep duration, although according to multiple 
studies self-reports correlate with the actigraphy data 
[26]. Another limiting factor is the cross-sectional 
design of our study. Short or long sleep duration is 
not always habitual. It might result from common 
sleep disorders (e.g., decrease in sleep time and low 
sleep quality in insomniacs, sleep apnea-related sig-
nificant reduction in sleep quality). We also did not 
analyze the factors limiting sleep duration — the 
duration of work time, the time which subjects waste 
to get to the workplace, work schedule, chronotype 
and etc., because these factors were not included in 
the structured interview according to the primary 
design of the ESSE-RF study.
Conclusions
Our data support the concept of the relation between 
sleep and cardiometabolic disorders and provide ad-
ditional evidence on the unfavorable impact of ex-
treme sleep duration variations. We demonstrated 
that sleep duration is highly variable in Russian pop-
ulation with significant prevalence of short sleepers. 
However, unlike published data, in our cohort not 
all cardiovascular diseases were associated with sleep 
duration. The multivariable odds ratio was higher 
for obesity in short-sleepers compared with those 
who slept 7–8 hours. Meanwhile the U-shaped as-
sociation was found for coronary artery disease. As-
sociation with myocardial infarction is characterized 
arterial hypertension 2019, vol. 23, no. 4
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by the J-shaped relation. There were no associations 
for hypertension, diabetes mellitus and stroke. We 
believe that our results provide important informa-
tion for the understanding of sleep epidemiology and 
relation between sleep and cardiovascular risk.
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